NAD+ IV Drips: What They Actually Do (And What the Science Still Doesn’t Know)
NAD+ IV Drips: What They Actually Do (And What the Science Still Doesn't Know)
Few treatments get talked about with as much confidence, on both sides, as NAD+ IV drips. Ask one person and it's the secret to feeling twenty years younger. Ask another and it's an overpriced saline bag. The truth sits in the middle and is more interesting than either take. Here's what NAD+ actually is, what the evidence genuinely supports, and where the science is still catching up to the marketing.
What Is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell in your body. It plays a central role in converting food into cellular energy, supporting DNA repair, and activating a group of proteins called sirtuins, which are involved in how cells age and regulate themselves.
NAD+ levels aren't fixed. They decline naturally with age, and that decline has been linked in research to slower cellular energy production and reduced capacity for DNA repair.
Why People Are Interested in NAD+ Infusions
The logic is fairly simple: if levels decline with age, replenishing them intravenously might support the processes NAD+ is involved in. Going straight into the bloodstream also bypasses the digestive breakdown that limits how much of an oral NAD+ precursor, like NMN or nicotinamide riboside, actually gets absorbed.
Here's the part that surprises most people: the longest clinical track record for NAD+ IV therapy has nothing to do with aesthetics. It was first used in the 1960s to help manage symptoms of alcohol and opioid withdrawal, and that remains the area with the most consistent clinical evidence behind it.
What the Evidence Actually Supports
Worth being upfront about this, since marketing around NAD+ commonly overstates the science:
- Withdrawal support has the strongest evidence base, largely from established clinical use in addiction medicine.
- Cellular energy and DNA repair mechanisms are well understood in laboratory and animal studies, though human data on IV infusion specifically remains limited.
- Cognitive clarity, fatigue and "anti-ageing" benefits are commonly reported anecdotally by patients but haven't yet been confirmed in large, controlled human trials.
- General wellness and longevity claims are, at this stage, mechanistically plausible rather than clinically proven. Research here is still developing.
None of this means NAD+ therapy is without merit. It means the evidence base is still forming, not settled. A qualified practitioner should be able to explain plainly what's backed by evidence and what's still an emerging area of research, rather than blurring the two.
What to Expect During an Infusion
NAD+ infusions are typically administered slowly under clinical supervision, often over one to a few hours depending on the dose and individual tolerance. At Skinnotion, NAD+ IV therapy is administered under the care of Dr Hung Nguyen (AHPRA registration MED0001176347). Some people notice mild effects during the infusion, such as nausea, flushing or tightness in the chest, which usually settle when the infusion rate is slowed. For this reason, NAD+ IV therapy should only be undertaken in a properly supervised clinical setting.
Is NAD+ IV Therapy Right for You?
Because the evidence base is still developing, NAD+ therapy is best considered as part of a broader conversation about your individual health and goals, rather than a guaranteed outcome. Suitability is determined through consultation with a qualified practitioner, who can review your health history and talk you through realistic expectations rather than the highlight reel version.
Still Have Questions?
If you'd like to talk through whether NAD+ IV therapy is relevant to your situation, feel free to pop in for a consultation with our doctor.
Book a ConsultationFurther Reading
Reyna et al. (2026), Frontiers in Aging: a real-world pilot study comparing tolerability and safety markers of IV NAD+ and IV nicotinamide riboside.
Yoshino et al., Endocrine Journal: a clinical safety trial examining intravenous NAD+ precursor administration in healthy adults.